Synopsis
Synopsis
0
JDMF
0
EU WC
0
VMF
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Contugesic
2. Df 118
3. Dhc Continus
4. Dhc Mundipharma
5. Dicodin
6. Dihydrocodeine
7. Dihydrocodeine Acetate, (5alpha,6alpha)-isomer
8. Dihydrocodeine Hydrochloride, (5alpha,6alpha)-isomer
9. Dihydrocodeine Phosphate (1:1), (5alpha,6alpha)-isomer
10. Dihydrocodeine Tartrate (1:1), (5alpha,6alpha)-(r-(r*,r*))-isomer
11. Dihydrocodeine Tartrate (1:1), (5alpha,6beta)-(r-(r*,r*))-isomer
12. Dihydrocodeine, (5alpha,6alpha,14alpha)-isomer
13. Dihydrocodeine, (5alpha,6beta)-isomer
14. Dihydrocodeine, (5alpha,6beta,14alpha)-isomer
15. Dihydrocodeine, Thiocyanate Salt (5alpha,6alpha)-isomer
16. Paracodin
17. Paracodina
18. Paramol 118
19. Rikodeine
20. Tiamon
21. Tosidrin
1. 5965-13-9
2. Df 118
3. Codeine, Dihydro-, Tartrate (1:1)
4. 8lxs95bsa9
5. Tuscodin
6. Dihydrocodeine Bitartrate [usp]
7. Paracodeine Bitartrate
8. Dihydrocodeine Tartrate
9. Dihydrocodeine Acid Tartrate
10. Dihydrocodeine Hydrogen Tartrate
11. Dihydrocodeine Bitartrate (usp)
12. Unii-8lxs95bsa9
13. Nsc-117857
14. (4r,4ar,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,4a,5,6,7,7a,13-octahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;(2r,3r)-2,3-dihydroxybutanedioic Acid
15. Einecs 227-747-7
16. Nsc 117857
17. Dtxsid00975047
18. Dihydrocodeine Tartrate [mi]
19. Dihydrocodeine Tartrate [mart.]
20. Dihydrocodeine Bitartrate [vandf]
21. Dihydrocodeine Bitartrate [usp-rs]
22. Dihydrocodeine Bitartrate [who-dd]
23. D03825
24. Dihydrocodeine Bitartrate [orange Book]
25. Dihydrocodeine Bitartrate [usp Monograph]
26. Trezix Component Dihydrocodeine Bitartrate
27. Dhc Plus Component Dihydrocodeine Bitartrate
28. Dihydrocodeine Bitartrate Component Of Dhc Plus
29. Dihydrocodeine Hydrogen Tartrate [ep Monograph]
30. Q27270730
31. Synalgos-dc Component Dihydrocodeine Bitartrate
32. Dihydrocodeine Bitartrate Component Of Synalgos-dc
33. Synalgos-dc-a Component Dihydrocodeine Bitartrate
34. Dihydrocodeine Bitartrate Component Of Synalgos-dc-a
35. 4,5.alpha.-epoxy-3-methoxy-17-methylmorphinan-6a-ol (+)-tartrate (salt)
36. 4,5alpha-epoxy-6alpha-hydroxy-3-methoxy-17-methylmorphinan Hydrogen (r-(r*,r*))-tartrate
37. Morphinan-6-alpha-ol, 4,5-alpha-epoxy-3-methoxy-17-methyl-, Tartrate (1:1)
38. Morphinan-6alpha-ol, 4,5alpha-epoxy-3-methoxy-17-methyl-, Tartrate (1:1) (salt)
39. (4r,4ar,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,4a,5,6,7,7a,13-octahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol;(2r,3r)-2,3-dihydroxybutanedioic Acid
40. Morphinan-6-ol, 4,5-epoxy-3-methoxy-17-methyl-, (5.alpha.,6.alpha.)-2,3-dihydroxybutanedioate (1:1) (salt)
41. Morphinan-6-ol, 4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-, (r-(r*,r*))-2,3-dihydroxybutanedioate (1:1) (salt)
Molecular Weight | 451.5 g/mol |
---|---|
Molecular Formula | C22H29NO9 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 4 |
Exact Mass | 451.18423150 g/mol |
Monoisotopic Mass | 451.18423150 g/mol |
Topological Polar Surface Area | 157 Ų |
Heavy Atom Count | 32 |
Formal Charge | 0 |
Complexity | 605 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 7 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Analgesics, Opioid
Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)
Certificate Number : R1-CEP 2003-209 - Rev 01
Issue Date : 2015-02-13
Type : Chemical
Substance Number : 1776
Status : Valid
Registrant Name : Samung Industrial Co., Ltd.
Registration Date : 2021-03-10
Registration Number : 20210310-209-J-865
Manufacturer Name : Macfarlan Smith Limited
Manufacturer Address : 10 Wheatfield Road, Edinburgh, EH11 2QA, United Kingdom
Available Reg Filing : ROW, CN |
Registrant Name : Baeksu Pharmaceutical Co., Ltd.
Registration Date : 2021-03-10
Registration Number : 20210310-209-J-865(A)
Manufacturer Name : Macfarlan Smith Limited
Manufacturer Address : 10 Wheatfield Road, Edinburgh, EH11 2QA, United Kingdom
Available Reg Filing : ROW, CN |
GDUFA
DMF Review : Reviewed
Rev. Date : 2012-10-24
Pay. Date : 2012-12-04
DMF Number : 191
Submission : 1956-01-24
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32354
Submission : 2019-09-27
Status : Active
Type : II
NDC Package Code : 61960-0100
Start Marketing Date : 2018-12-17
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6009
Submission : 1985-09-27
Status : Inactive
Type : II
Certificate Number : R1-CEP 2004-187 - Rev 01
Issue Date : 2011-04-08
Type : Chemical
Substance Number : 1776
Status : Valid
Certificate Number : R1-CEP 2008-018 - Rev 01
Issue Date : 2021-07-07
Type : Chemical
Substance Number : 1776
Status : Valid
Registrant Name : Nosa Chemical Co., Ltd.
Registration Date : 2020-04-21
Registration Number : 20200421-209-J-609
Manufacturer Name : Saneca Pharmaceuticals as
Manufacturer Address : Nitrianska 100, 920 27 Hlohovec, Slovak Republic
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32354
Submission : 2019-09-27
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2012-10-24
Pay. Date : 2012-12-04
DMF Number : 191
Submission : 1956-01-24
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6009
Submission : 1985-09-27
Status : Inactive
Type : II
Dihydrocodeine Hydrogen Tartrate
Certificate Number : R1-CEP 2003-209 - Rev 01
Status : Valid
Issue Date : 2015-02-13
Type : Chemical
Substance Number : 1776
Dihydrocodeine Hydrogen Tartrate
Certificate Number : R1-CEP 2009-225 - Rev 02
Status : Valid
Issue Date : 2020-08-21
Type : Chemical
Substance Number : 1776
Dihydrocodeine Hydrogen Tartrate
Certificate Number : R1-CEP 2004-187 - Rev 01
Status : Valid
Issue Date : 2011-04-08
Type : Chemical
Substance Number : 1776
Dihydrocodeine Hydrogen Tartrate
Certificate Number : R1-CEP 2008-018 - Rev 01
Status : Valid
Issue Date : 2021-07-07
Type : Chemical
Substance Number : 1776
Registrant Name : Baeksu Pharmaceutical Co., Ltd.
Registration Date : 2021-03-10
Registration Number : 20210310-209-J-865(A)
Manufacturer Name : Macfarlan Smith Limited
Manufacturer Address : 10 Wheatfield Road, Edinburgh, EH11 2QA, United Kingdom
Registrant Name : Samung Industrial Co., Ltd.
Registration Date : 2021-03-10
Registration Number : 20210310-209-J-865
Manufacturer Name : Macfarlan Smith Limited
Manufacturer Address : 10 Wheatfield Road, Edinburgh, EH11 2QA, United Kingdom
Registrant Name : Samung Industrial Co., Ltd.
Registration Date : 2021-05-11
Registration Number : 20210511-209-J-706
Manufacturer Name : ALKALOIDA Chemical Company Z...
Manufacturer Address : Kabay Janos u.29., Tiszavasvari, 4440, Hungary
Registrant Name : Baeksu Pharmaceutical Co., Ltd.
Registration Date : 2021-09-07
Registration Number : 20210511-209-J-706(A)
Manufacturer Name : Alkaloida Chemical Company Z...
Manufacturer Address : Kabay Janos u.29., Tiszavasvari, 4440, Hungary
Registrant Name : Aging Life Science Co., Ltd.
Registration Date : 2018-10-23
Registration Number : 20181023-209-J-31
Manufacturer Name : SALARSSpA@[Starting Material...
Manufacturer Address : Via San Francesco, 5 22100 COMO, Italy@[Starting Material Manufacturer] Princes Highw...
Registrant Name : Nosa Chemical Co., Ltd.
Registration Date : 2020-04-21
Registration Number : 20200421-209-J-609
Manufacturer Name : Saneca Pharmaceuticals as
Manufacturer Address : Nitrianska 100, 920 27 Hlohovec, Slovak Republic
Registrant Name : Samung Industrial Co., Ltd.
Registration Date : 2024-02-20
Registration Number : 20240220-209-J-1606
Manufacturer Name : Toprak Mahsulleri Ofisi Gene...
Manufacturer Address : Kızılhöyük Mevkii Bolvadin, Afyonkarahisar, Türkiye
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
CAS Number : 3861-72-1
End Use API : Dihydrocodeine Tartrate
About The Company : Established in 1997, Temad Co. is one of the largest producers of APIs in Iran & an innovative manufacturer of narcotic and non-narcotic products of world-class...
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : DF 118 Injection
Dosage Form : INJ
Dosage Strength : 50mg/ml
Packaging : 1X5mg/ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : DF 118 Injection
Dosage Form : INJ
Dosage Strength : 50mg/ml
Packaging : 1X10mg/ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Df 118
Dosage Form : TAB
Dosage Strength : 30mg
Packaging : 100X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : DISCN
Registration Country : USA
ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE
Brand Name : ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 356.4MG;30MG;16MG
Packaging :
Approval Date : 1997-08-26
Application Number : 40109
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE
Brand Name : ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE
Dosage Form : TABLET;ORAL
Dosage Strength : 712.8MG;60MG;32MG
Packaging :
Approval Date : 1999-04-28
Application Number : 40316
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE
Brand Name : ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE
Dosage Form : TABLET;ORAL
Dosage Strength : 712.8MG;60MG;32MG
Packaging :
Approval Date : 2007-04-03
Application Number : 40701
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : Generic
Registration Country : South Korea
Brand Name : Dicode
Dosage Form : ER TABLET
Dosage Strength : 60MG
Packaging : 100 T
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Korea
Regulatory Info : DISCN
Registration Country : USA
ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE
Brand Name : ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE
Dosage Form : TABLET;ORAL
Dosage Strength : 325MG;30MG;16MG
Packaging :
Approval Date : 2016-09-30
Application Number : 204209
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : Malaysia
Brand Name : P.P. DIHYDROCODEINE TABLET
Dosage Form : Tablet
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Malaysia
Regulatory Info : DISCN
Registration Country : USA
ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE
Brand Name : ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE
Dosage Form : TABLET;ORAL
Dosage Strength : 712.8MG;60MG;32MG
Packaging :
Approval Date : 2006-09-22
Application Number : 40637
Regulatory Info : DISCN
Registration Country : USA
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
47
PharmaCompass offers a list of Dihydrocodeine Tartrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dihydrocodeine Tartrate manufacturer or Dihydrocodeine Tartrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dihydrocodeine Tartrate manufacturer or Dihydrocodeine Tartrate supplier.
PharmaCompass also assists you with knowing the Dihydrocodeine Tartrate API Price utilized in the formulation of products. Dihydrocodeine Tartrate API Price is not always fixed or binding as the Dihydrocodeine Tartrate Price is obtained through a variety of data sources. The Dihydrocodeine Tartrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Fardi brand of dihydrocodeine bitartrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fardi brand of dihydrocodeine bitartrate, including repackagers and relabelers. The FDA regulates Fardi brand of dihydrocodeine bitartrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fardi brand of dihydrocodeine bitartrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Fardi brand of dihydrocodeine bitartrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Fardi brand of dihydrocodeine bitartrate supplier is an individual or a company that provides Fardi brand of dihydrocodeine bitartrate active pharmaceutical ingredient (API) or Fardi brand of dihydrocodeine bitartrate finished formulations upon request. The Fardi brand of dihydrocodeine bitartrate suppliers may include Fardi brand of dihydrocodeine bitartrate API manufacturers, exporters, distributors and traders.
click here to find a list of Fardi brand of dihydrocodeine bitartrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Fardi brand of dihydrocodeine bitartrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Fardi brand of dihydrocodeine bitartrate active pharmaceutical ingredient (API) in detail. Different forms of Fardi brand of dihydrocodeine bitartrate DMFs exist exist since differing nations have different regulations, such as Fardi brand of dihydrocodeine bitartrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Fardi brand of dihydrocodeine bitartrate DMF submitted to regulatory agencies in the US is known as a USDMF. Fardi brand of dihydrocodeine bitartrate USDMF includes data on Fardi brand of dihydrocodeine bitartrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Fardi brand of dihydrocodeine bitartrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Fardi brand of dihydrocodeine bitartrate suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Fardi brand of dihydrocodeine bitartrate Drug Master File in Korea (Fardi brand of dihydrocodeine bitartrate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Fardi brand of dihydrocodeine bitartrate. The MFDS reviews the Fardi brand of dihydrocodeine bitartrate KDMF as part of the drug registration process and uses the information provided in the Fardi brand of dihydrocodeine bitartrate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Fardi brand of dihydrocodeine bitartrate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Fardi brand of dihydrocodeine bitartrate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Fardi brand of dihydrocodeine bitartrate suppliers with KDMF on PharmaCompass.
A Fardi brand of dihydrocodeine bitartrate CEP of the European Pharmacopoeia monograph is often referred to as a Fardi brand of dihydrocodeine bitartrate Certificate of Suitability (COS). The purpose of a Fardi brand of dihydrocodeine bitartrate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Fardi brand of dihydrocodeine bitartrate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Fardi brand of dihydrocodeine bitartrate to their clients by showing that a Fardi brand of dihydrocodeine bitartrate CEP has been issued for it. The manufacturer submits a Fardi brand of dihydrocodeine bitartrate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Fardi brand of dihydrocodeine bitartrate CEP holder for the record. Additionally, the data presented in the Fardi brand of dihydrocodeine bitartrate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Fardi brand of dihydrocodeine bitartrate DMF.
A Fardi brand of dihydrocodeine bitartrate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Fardi brand of dihydrocodeine bitartrate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Fardi brand of dihydrocodeine bitartrate suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Fardi brand of dihydrocodeine bitartrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Fardi brand of dihydrocodeine bitartrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Fardi brand of dihydrocodeine bitartrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Fardi brand of dihydrocodeine bitartrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Fardi brand of dihydrocodeine bitartrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Fardi brand of dihydrocodeine bitartrate suppliers with NDC on PharmaCompass.
Fardi brand of dihydrocodeine bitartrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fardi brand of dihydrocodeine bitartrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fardi brand of dihydrocodeine bitartrate GMP manufacturer or Fardi brand of dihydrocodeine bitartrate GMP API supplier for your needs.
A Fardi brand of dihydrocodeine bitartrate CoA (Certificate of Analysis) is a formal document that attests to Fardi brand of dihydrocodeine bitartrate's compliance with Fardi brand of dihydrocodeine bitartrate specifications and serves as a tool for batch-level quality control.
Fardi brand of dihydrocodeine bitartrate CoA mostly includes findings from lab analyses of a specific batch. For each Fardi brand of dihydrocodeine bitartrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fardi brand of dihydrocodeine bitartrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Fardi brand of dihydrocodeine bitartrate EP), Fardi brand of dihydrocodeine bitartrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fardi brand of dihydrocodeine bitartrate USP).